Better Health,
Brighter Future
Takeda at TICAD
TFTA members of Takeda
TFTA members Takeda, Giles Platford (center, back) and Haruhiko Hirate (second left, back), with Japanese Prime Minister Shinzo Abe
(third left, front), TICAD.
Panel Discussion
Takeda's panel discussion at TICAD, where panelists discussed the range of access barriers across sub-Saharan Africa.
Panel Discussion
Delegates pose questions to panelists during Takeda's panel discussion around the access challenges across sub-Saharan Africa.
Panel Discussion
Dr. Raj Jutley, Founder and Chairman of the Pan Africa Heart Foundation (PANAHF), one of Takeda's key
partners, responds to a question from the floor.
Panel Discussion
Giles Platford outlines Takeda's commitment to addressing the access barriers in sub-Saharan Africa
Takeda’s Nairobi Office Opening
Giles Platford officially opens Takeda's new Nairobi office at a ribbon-cutting ceremony attended by Takeda employees,
government officials and media.
Takeda’s Nairobi Office Opening
Giles Platford, Isabel Torres, Global Head of AtM, and Philip Towle, Associate Director, AtM are joined by members of the Kenya
Oncology Foundation and local media.
Takeda’s Nairobi Office Opening
Giles Platford, President, Emerging Markets unveils Takeda's bold, new Access to Medicines strategy, presenting how Takeda aims to break down
patient access barriers in sub-Saharan Africa and around the world.
Takeda’s Nairobi Office Opening
Kibachio Joseph Mwangi, Head of the Non-Communicable Diseases Division at Kenya's Ministry of Health, pictured here with Giles Platford and
Haruhiko Hirate at the opening of Takeda's new Nairobi office.
Takeda’s Nairobi Office Opening
Giles Platford, Haruhiko Hirate and Isabel Torres are joined here by Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation,
Kibachio Joseph Mwangi.
Takeda’s Nairobi Office Opening
Takeda's Haruhiko Hirate at the opening of Takeda's new Nairobi office.
Takeda Nairobi Office opened
A member of the newly formed Kenyan Cancer Foundation, which was promoted by Takeda, signed a memorandum of understanding (MOU).
Takeda Nairobi Office opened
Haruhiko Hirate provided closing remarks after the official opening of the new Armed Forces Nairobi office.
Visit Kajiado County
Road from Nairobi to Caquado County.
Visit Kajiado County
Giles Platford discusses the screening of Dr. Raj Jutley of PANAHF and members of the AtM Council of Takeda at the Kajiada County Hospital entrance.
Visit to Kajiado County
Kajiada County Hospital
Visit to Kajiado County
A PANAHF healthcare professional screens a patient for diabetes and hypertension, the results of which are available on the same day.
Visit Kajiado County
PANAHF Healthcare Professionals Screening Patients for Diabetes and Hypertension, Results Available on Same Day
Visit to Kajiado County
Isabel Torres meeting patients and their families in the waiting area at Kajiada County Hospital.
Visit to Kajiado County
On August 26, 2016, we proudly unveiled Takeda's bold, new Access to Medicines strategy at the sixth annual Tokyo International Conference of Africa's Development (TICAD) in Nairobi, Kenya.
During the conference, we also announced new partnerships with the University of Nairobi, the Elewa Cancer Foundation and the Pan African Heart Foundation. Takeda also hosted a panel discussion. Those present at the conference included Japan's Prime Minister Shinzo Abe and Takeda leaders Giles Platford, President, Emerging Markets Business Unit and Haruhiko Hirate, Corporate Officer, Corporate Communications & Public Affairs.
Panel Discussion
To launch the new Access to Medicines strategy, Giles Platford, President, Emerging Markets Business Unit, and Haruhiko Hirate, Corporate Officer, Corporate Communications & Public Affairs, were joined by some of Takeda's most important stakeholders for a panel discussion which focused on the unmet medical needs in Africa, especially in the area of non-communicable diseases.
"We aim to build sustainable approaches to tackle multiple barriers that limit access to medicines for patient in areas such as Latin America, Asia Pacific and Sub-Saharan Africa," said Giles.
Takeda's Nairobi Office Opening
As part of our new Access to Medicines strategy, Takeda has initiated a not-for-profit approach in Sub-Saharan Africa (SSA). This approach seeks to position Kenya as a Center of Excellence (CoE) in the diagnosis and treatment of oncology/hematology diseases, and will see us collaborating closely with local partners to ensure the sustainability and longevity of our efforts across the region.
"To make a sustainable contribution, Takeda will work alongside governments, NGOs, healthcare professionals, patient associations and local community in multiple Public-Private Partnerships. The opening of our Nairobi office is a significant step forward in helping forge those collaborations and in enabling patients in the region gain better access to medicines," commented Isabel Torres, Takeda's Global Head, Access to Medicines.
Visit to Kajiado County
Takeda's bold, new Access to Medicines strategy will focus on increasing access to some of its most innovative medicines in the areas of oncology and specialty gastroenterology, as well as its vaccine candidates for communicable diseases such as dengue and chikungunya.
In addition to these core focus areas, Takeda is also partnering with Pan Africa Heart Foundation to run mobile screenings for diabetes and hypertension, which are rising threats across the region as the middle class population grows and lifestyles evolve.
After the TICAD conference, Takeda's delegate travelled from Nairobi to Kajiado County, a rural area north of Nairobi, with the team from PANAHF, to see a screening firsthand, and to understand the importance of helping to diagnose diabetes and hypertension in this region.